Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still’s disease
Piero Ruscitti, Francesco Ursini, Onorina Berardicurti, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 1, pp. 321-329
Closed Access | Times Cited: 21

Showing 21 citing articles:

Cytokine Storm Syndrome
Randy Q. Cron, Gaurav Goyal, W. Winn Chatham
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 321-337
Open Access | Times Cited: 94
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 30
Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis
Wenxin Ou, Yunze Zhao, Ang Wei, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 729-739
Open Access | Times Cited: 14
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Piero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 7-8, pp. 103581-103581
Closed Access | Times Cited: 5
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 7, pp. 1141-1152
Closed Access | Times Cited: 4
Heterogeneity of macrophage activation syndrome and treatment progression
Yuanji Dong, Ting Wang, Huaxiang Wu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Toward a personalized therapy of Still’s disease based on immunologic endotypes: a narrative review
Po‐Ku Chen, Shiow-Jiuan Wey, Der‐Yuan Chen
Expert Review of Clinical Immunology (2025)
Closed Access
Marked exacerbation of resolving macrophage activation syndrome in a patient with adult-onset Still’s disease following one dose of granulocyte colony-stimulating factor
A Petrassi, Connor R. Buechler, Priyanjali Pulipati, et al.
BMJ Case Reports (2025) Vol. 18, Iss. 2, pp. e262024-e262024
Closed Access
Fever of Unknown Origin: Clinical Significance of the Etiology and Common Inflammatory Parameters
Nana Xie, Wencong Zhang, Fangbing Tian, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 112, Iss. 3, pp. 116801-116801
Closed Access
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
RMD Open (2023) Vol. 9, Iss. 4, pp. e003419-e003419
Open Access | Times Cited: 9
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome
Shunli Tang, Changyi Yang, Sheng Li, et al.
Journal of Autoimmunity (2022) Vol. 133, pp. 102929-102929
Closed Access | Times Cited: 14
AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis
Ruru Guo, Xuesong Liu, Yixuan Li, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 4, pp. 1636-1644
Closed Access | Times Cited: 12
The latest advances in the use of biological DMARDs to treat Still’s disease
Ilenia Di Cola, Piero Ruscitti
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 63-75
Closed Access | Times Cited: 2
Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud
Jinming Yang, Bing Yan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still’s disease
Tomoka Hiyama, Kazuhiro Kurasawa, Anna Hasegawa, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3407-3416
Closed Access | Times Cited: 4
The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still’s disease
Huihui Chi, Xinyue Hong, Ningqi Dai, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 7, pp. 1987-1997
Closed Access | Times Cited: 4
Identification of novel cytokine to judge the diagnosis and clinical phenotype of adult-onset Still’s disease
Shuhei Yoshida, Yuya Fujita, Tomohiro Koga, et al.
Immunological Medicine (2024), pp. 1-12
Open Access | Times Cited: 1
Clinical features and serum cytokine profiles of elderly-onset adult-onset Still’s disease
Mizuki Yagishita, Hiroto Tsuboi, Yuki Kuroda, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
Luca Navarini, Marta Vomero, Damiano Currado, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Perspectives on the use of non-biological pharmacotherapy for adult-onset Still’s disease
Ilenia Di Cola, Paola Cipriani, Piero Ruscitti
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 14, pp. 1577-1587
Closed Access | Times Cited: 5
Epidemiology, characteristics, treatments, and outcomes of adult-onset Still's disease in Afro-Caribbeans: Results from a population-based study in Martinique, French West Indies
Eleonore de Fritsch, Fabienne Louis‐Sidney, Arthur M. Felix, et al.
Journal of Autoimmunity (2023) Vol. 139, pp. 103086-103086
Open Access
Page 1

Scroll to top